ES420458A1 - Procedimiento para la preparacion de heptapeptidos. - Google Patents

Procedimiento para la preparacion de heptapeptidos.

Info

Publication number
ES420458A1
ES420458A1 ES420458A ES420458A ES420458A1 ES 420458 A1 ES420458 A1 ES 420458A1 ES 420458 A ES420458 A ES 420458A ES 420458 A ES420458 A ES 420458A ES 420458 A1 ES420458 A1 ES 420458A1
Authority
ES
Spain
Prior art keywords
heptapeptides
novel
gastrin activity
gastrin
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES420458A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Farbwerke Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Farbwerke Hoechst AG filed Critical Hoechst AG
Publication of ES420458A1 publication Critical patent/ES420458A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES420458A 1972-11-17 1973-11-12 Procedimiento para la preparacion de heptapeptidos. Expired ES420458A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2256445A DE2256445C3 (de) 1972-11-17 1972-11-17 Heptapeptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
ES420458A1 true ES420458A1 (es) 1976-04-01

Family

ID=5862026

Family Applications (1)

Application Number Title Priority Date Filing Date
ES420458A Expired ES420458A1 (es) 1972-11-17 1973-11-12 Procedimiento para la preparacion de heptapeptidos.

Country Status (15)

Country Link
US (1) US3931141A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5724778B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT329203B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE807501A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1012965A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH587802A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2256445C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK147733C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES420458A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2206948B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1429700A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL43632A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL181331C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE394426B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA738785B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2628006C2 (de) * 1976-06-23 1986-11-27 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
DE3061586D1 (en) * 1979-04-30 1983-02-17 Max Planck Gesellschaft Pancreozymin-cholezystokinin active peptides, process for their preparation and pharmaceutical compositions containing them
US4530836A (en) * 1983-05-31 1985-07-23 Amano Pharmaceutical Co., Ltd. Peptide
IT1204430B (it) * 1986-01-10 1989-03-01 Alfio Bertolini Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
US5023077A (en) * 1989-01-24 1991-06-11 Aphton Corporation Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
DE69014137T2 (de) * 1989-01-24 1995-06-08 Aphton Corp., Woodland, Calif. Immunogenische Zusammensetzungen gegen Gastrin-Peptide.
US6861510B1 (en) 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
DE69827621T9 (de) * 1997-05-12 2007-06-06 Aphton Corp., Woodland Immunogene zusammensetzungen gegen den cck-b-gastrin-rezeptor und verfahren zur behandlung von tumoren
JP2002515458A (ja) * 1998-05-15 2002-05-28 アフトン・コーポレーシヨン 高ガストリン血症の予防および処置
US20030068326A1 (en) * 1998-05-15 2003-04-10 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
WO2002076499A2 (en) 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US6810583B2 (en) * 2001-08-07 2004-11-02 International Business Machines Corporation Coupling of conductive vias to complex power-signal substructures
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
KR20050118690A (ko) 2003-03-28 2005-12-19 애프톤 코포레이션 가스트린 호르몬 면역어세이
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
CA2561405C (en) * 2004-03-29 2014-01-21 Receptor Biologix, Inc. Monoclonal antibodies to gastrin hormone
ES2400058T3 (es) * 2004-09-22 2013-04-05 Cancer Advances, Inc. Anticuerpos monoclonales para progastrina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042487A (en) * 1964-06-25 1966-09-14 Ici Ltd Polypeptide derivatives
GB1224576A (en) * 1968-08-24 1971-03-10 Tanabe Seiyaku Co Novel tetrapeptide amides and the preparation thereof

Also Published As

Publication number Publication date
ATA964673A (de) 1975-07-15
DK147733C (da) 1985-06-17
FR2206948B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-01-13
CH587802A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-05-13
AT329203B (de) 1976-04-26
DK147733B (da) 1984-11-26
NL7315444A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-05-21
CA1012965A (en) 1977-06-28
JPS504067A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-01-16
DE2256445C3 (de) 1981-11-05
NL181331B (nl) 1987-03-02
AU6249773A (en) 1975-05-15
SE394426B (sv) 1977-06-27
NL181331C (nl) 1987-08-03
US3931141A (en) 1976-01-06
DE2256445B2 (de) 1980-11-20
IL43632A0 (en) 1974-03-14
DE2256445A1 (de) 1974-05-22
ZA738785B (en) 1974-10-30
GB1429700A (en) 1976-03-24
IL43632A (en) 1976-09-30
FR2206948A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-06-14
BE807501A (fr) 1974-05-20
JPS5724778B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-05-26

Similar Documents

Publication Publication Date Title
ES420458A1 (es) Procedimiento para la preparacion de heptapeptidos.
CA943129A (en) Process for the production of n-(1,1,1-trisubstituted)-methylazoles
ES414335A1 (es) Procedimiento para la obtencion de revestimientos de poliu-retano.
IT1060512B (it) Procedimento per la produzione di polveri per cariche di lancio in particolare polveri di nitroguanidina
NL7509283A (nl) Werkwijze voor de bereiding van etheen-1,3-bu- tadieen copolymeren met hoge opbrengsten.
ES441404A1 (es) Un procedimiento de preparacion de acido 5-fluor-2-metil-1- (p-metilsulfinil-benciliden) indenil-3-acetico.
IT956299B (it) Procedimento per la produzione di corpi sagomati di carbonio
IT952889B (it) Procedimento per la fabbricazione di corpi stampati di carbone
CS180612B2 (en) Mode of production of alkylesters 2,5-dimethyl-furane-3-carboxyl acid
YU264480A (en) Process for obtaining the p-biphenylester of 11,15-bis-(tetrahydropyran-5-yloxy)-16-substituted tetranorprostadienic acid
NL7412037A (nl) Werkwijze ter bereiding van cyclopropaancarbon- zuurnitrile.
YU261373A (en) Improved amination process with substituted of the amino group
ZA744354B (en) Novel amino acids, and their production and use
AT333767B (de) Verfahren zur herstellung von chinoxalincarboxamid-1,4-dioxiden
ES440055A1 (es) Un procedimiento para la preparacion de acidos 19, 20-bis- norprotanoicos.
IT985728B (it) Procedimento per la fabbricazione di acciaio a basso tenore di carbonio
NL971002I1 (nl) Werkwijze ter bereiding van 4-amino-5-chloor-1-fenylpyridazon-(6).
CS182252B2 (en) Process for the enzymatic producting l-malic acid
BE587832A (fr) Procédé de production d'électrodes en carbone.
JPS5230718A (en) Process for making metallic material with high toughness
CA1001175A (en) Process for the racemates splitting of d, 1-phenyl propanol amine
CA1022572A (en) Process for the preparation of 2-amino-3,5-dibromo-benzylamines
CA971005A (en) Properly weldable, corrosion resistant structural steel of high yield point
IT1059818B (it) Procedimento per la produzione di alfa,alfa diaril beta(amino terz) propanoli
CA892035A (en) Process for the production of n,n'-substituted formamidines